期刊文献+
共找到546篇文章
< 1 2 28 >
每页显示 20 50 100
Macrophage involvement in the pathological evolution of ulcerative colitis-associated colon cancer and progress of related traditional Chinese medicine drug interventions
1
作者 Jun-Yu Ke Jin-Bin Song +11 位作者 Long Li Zhen-Fan He Zhuo-Jian Huang Zheng-Lin Liu Gui-Rong Chen Su-Ru Wen Heng-Li Zhou Hui-Lin Ma Qun Du Yong-Qiang Wu Yan-Wu Li Xin-Lin Chen 《Traditional Medicine Research》 2023年第8期37-52,共16页
Intestinal macrophages are essential players in intestinal inflammation and intestinal immune homeostasis.Intestinal macrophages have the ability to polarize into two distinct phenotypes based on various environmental... Intestinal macrophages are essential players in intestinal inflammation and intestinal immune homeostasis.Intestinal macrophages have the ability to polarize into two distinct phenotypes based on various environmental signals.These phenotypes include the typically activated pro-inflammatory M1 phenotype and the alternatively activated anti-inflammatory M2 phenotype.Under normal circumstances,intestinal macrophages prevent inflammatory damage to the gut.However,when genetic and environmental factors influence the polarization of intestinal macrophages,it can lead to an imbalance in M1/M2 macrophage activation and subsequently an imbalance in the control of intestinal inflammation.It transforms physiological inflammation into pathological intestinal damage.In patients with ulcerative colitis-associated cancer(UC-CRC),intestinal inflammatory disorders are closely associated with intestinal M1/M2 macrophage polarization imbalance.Consequently,restoring the polarization equilibrium of M1/M2 macrophages might be an evidence of traditional Chinese medicine in the treatment of UC-CRC,the pivotal role o effective measure to prevent and treat UC-CRC.This paper aims to examine the clinicalf macrophage polarization in UC-CRC pathogenesis,and the potential mechanisms of traditional Chinese medicine in regulating macrophage polarization to treat UC-CRC.Our goal is to provide novel insights into the clinical practice,basic research,and drug development of UC-CRC. 展开更多
关键词 ulcerative colitis ulcerative colitis-associated cancer macrophage polarization herbal compound herbal monomer signaling pathway
下载PDF
复方谷氨酰胺联合美沙拉嗪治疗溃疡性结肠炎的疗效及对血清IL-6、IL-10水平和血小板参数的影响
2
作者 黄阿妹 《中外医学研究》 2024年第24期46-49,共4页
目的:探讨溃疡性结肠炎(UC)患者使用复方谷氨酰胺联合美沙拉嗪治疗的效果。方法:选取2021年7月—2023年6月在福建医科大学附属第二医院治疗的84例UC患者作为研究对象,按随机法分为对照组(n=42)与观察组(n=42),分别予以美沙拉嗪、复方谷... 目的:探讨溃疡性结肠炎(UC)患者使用复方谷氨酰胺联合美沙拉嗪治疗的效果。方法:选取2021年7月—2023年6月在福建医科大学附属第二医院治疗的84例UC患者作为研究对象,按随机法分为对照组(n=42)与观察组(n=42),分别予以美沙拉嗪、复方谷氨酰胺联合美沙拉嗪治疗,两组均治疗8周。评价两组治疗效果,比较两组治疗前后Mayo评分、Geboes评分、血清炎症因子[C反应蛋白(CRP)、白细胞介素-6(IL-6)、白细胞介素-10(IL-10)]和血小板参数[血小板计数(PLT)、血小板体积(MPV)],并观察不良反应情况。结果:相比于对照组,观察组总有效率更高,差异有统计学意义(P<0.05);治疗后,相比于对照组,观察组Mayo评分更低,Geboes指数下降,差异有统计学意义(P<0.05);治疗后,观察组血清CRP、IL-6、IL-10和PLT水平低于对照组,MPV高于对照组,差异有统计学意义(P<0.05);两组不良反应发生率比较,差异无统计学意义(P>0.05)。结论:UC患者使用复方谷氨酰胺联合美沙拉嗪治疗效果较好,能够有效改善患者临床症状,促进肠黏膜愈合,减轻炎症反应。 展开更多
关键词 溃疡性结肠炎 美沙拉嗪 复方谷氨酰胺 炎症反应 血小板计数
下载PDF
复方黄柏液涂剂溻渍治疗Wagner 2-3级糖尿病足的疗效观察及其对血清炎症因子的影响 被引量:7
3
作者 王丽翔 黄仁燕 柳国斌 《安徽中医药大学学报》 CAS 2023年第1期36-39,共4页
目的观察复方黄柏液涂剂溻渍治疗Wagner 2-3级糖尿病足的临床疗效及其对炎症因子的影响。方法将符合纳入标准的52例糖尿病足Wagner 2-3级患者随机分为观察组和对照组,每组26例。观察组给予复方黄柏液涂剂溻渍治疗,对照组给予乳酸依沙吖... 目的观察复方黄柏液涂剂溻渍治疗Wagner 2-3级糖尿病足的临床疗效及其对炎症因子的影响。方法将符合纳入标准的52例糖尿病足Wagner 2-3级患者随机分为观察组和对照组,每组26例。观察组给予复方黄柏液涂剂溻渍治疗,对照组给予乳酸依沙吖啶溶液湿敷治疗,比较两组临床疗效、创面面积及血清炎症因子[白细胞介素-1(interleukin-1,IL-1)、白细胞介素-6(interleukin-6,IL-6)、肿瘤坏死因子-α(tumor necrosis factor-α,TNF-α)]变化。结果观察组临床疗效明显优于对照组(P<0.05);治疗后观察组创面面积明显小于对照组(P<0.05);治疗后观察组IL-1、IL-6、TNF-α水平均较治疗前显著降低(P<0.05),且明显低于对照组(P<0.05)。结论复方黄柏液涂剂溻渍治疗Wagner 2-3级糖尿病足,可以促进创面愈合,降低炎症因子水平,临床疗效确切。 展开更多
关键词 糖尿病足 复方黄柏液涂剂 溻渍术 炎症因子
下载PDF
产β-葡萄糖苷酶微生物的筛选鉴定及其在人参皂苷Compound K转化中的应用 被引量:6
4
作者 张庆锋 吕世鑫 +2 位作者 江雨欣 王丹丹 王洪涛 《山东农业科学》 北大核心 2021年第11期63-69,共7页
本试验用七叶苷培养基从西洋参(Panax quinquefolius)的根际土壤中筛选产β-葡萄糖苷酶的菌种,并通过转化试验发现一株可以高效转化人参皂苷Rb1为人参皂苷Compound K(C-K)的菌株。基于16S rDNA基因序列的系统进化树分析确定该菌株为耐... 本试验用七叶苷培养基从西洋参(Panax quinquefolius)的根际土壤中筛选产β-葡萄糖苷酶的菌种,并通过转化试验发现一株可以高效转化人参皂苷Rb1为人参皂苷Compound K(C-K)的菌株。基于16S rDNA基因序列的系统进化树分析确定该菌株为耐热科恩氏菌(Cohnella thermotolerans)。根据单因素试验结果,选取菌液浓度、反应pH值、反应时间3个因素,以C-K的含量为响应值,采用Box-Behnken中心组合试验设计3因素3水平的响应面试验,建立回归模型。确定优化的皂苷转化条件为反应pH 6.4、菌液浓度9.0×10^(8)cfu/mL、反应时间7.5 d,在该条件下人参皂苷转化率为78.36%。通过高效液相色谱分析该菌株转化人参皂苷Rb1的途径为Rb1→Rd→F2→C-K。本研究为稀有皂苷C-K的微生物转化提供了新的菌种来源,也为C-K的工业化生产提供了理论依据。 展开更多
关键词 菌株筛选 生物转化 Β-葡萄糖苷酶 人参皂苷RB1 人参皂苷compound K
下载PDF
基于NF-κB途径探讨溃疡性结肠炎发病机制及中药干预作用研究进展 被引量:5
5
作者 高飞云 刘婷 +4 位作者 张转红 王彦钧 张育贵 孙宇靖 李越峰 《中华中医药学刊》 CAS 北大核心 2023年第6期123-127,共5页
溃疡性结肠炎(ulcerative colitis,UC)是一种非特异性、复发性的慢性肠道炎症性疾病,发病机制尚不明确。目前治疗药物以氨基水杨酸类、皮质类固醇、免疫抑制剂等为主,但对UC患者疗效欠佳,有些患者因不良反应加重了身体负担。近年来中药... 溃疡性结肠炎(ulcerative colitis,UC)是一种非特异性、复发性的慢性肠道炎症性疾病,发病机制尚不明确。目前治疗药物以氨基水杨酸类、皮质类固醇、免疫抑制剂等为主,但对UC患者疗效欠佳,有些患者因不良反应加重了身体负担。近年来中药在治疗溃疡性结肠炎中疗效显著,且不良反应小,基于NF-κB信号通路对中药进一步深入治疗UC的文献进行综述,为中药治疗UC作用机制提供依据。 展开更多
关键词 溃疡性结肠炎 NF-ΚB信号通路 中药复方 中药活性成分 机制 中药干预
下载PDF
复方柏连制剂对小鼠抗炎镇痛作用及湿热型UC模型大鼠TNF-α、IL-6、IL-1β表达的影响 被引量:3
6
作者 郭媛媛 朱志坤 +4 位作者 王飘 王五兵 李思琪 陈凌云 余晓玲 《医药导报》 CAS 北大核心 2023年第8期1104-1109,共6页
目的探讨复方柏连灌肠剂和凝胶剂的急性毒性、抗炎镇痛和药效学作用,为临床安全用药提供思考方案。方法给小鼠以最大浓度24 h内重复2次灌肠,给大鼠以折算浓度灌肠7 d,分别观察其毒性反应和死亡情况;建立小鼠二甲苯致耳肿胀模型、冰醋酸... 目的探讨复方柏连灌肠剂和凝胶剂的急性毒性、抗炎镇痛和药效学作用,为临床安全用药提供思考方案。方法给小鼠以最大浓度24 h内重复2次灌肠,给大鼠以折算浓度灌肠7 d,分别观察其毒性反应和死亡情况;建立小鼠二甲苯致耳肿胀模型、冰醋酸致扭体模型、环境因素加三硝基苯磺酸(TNBS)/乙醇法致大鼠溃疡性结肠炎(UC)模型,分别观察复方柏连灌肠剂和凝胶剂药效学作用。结果复方柏连制剂灌肠最大给药量生药为161.6 g·kg^(-1),相当于人每日用量的96倍;复方柏连灌肠剂和凝胶剂大、中、小剂量组均能显著降低小鼠耳肿胀率,减少扭体次数,改善湿热型UC模型大鼠结肠组织的病理损伤及降低TNF-α、IL-6、IL-1β含量(P<0.05)。结论复方柏连灌肠剂和凝胶剂临床拟用剂量安全且对直肠黏膜没有刺激性,具有一定的抗炎、镇痛、治疗UC的作用。 展开更多
关键词 复方柏连制剂 溃疡型结肠炎 急性毒性 黏膜刺激性 抗炎作用 镇痛作用
下载PDF
复方苦参肠炎康片联合美沙拉嗪治疗对溃疡性结肠炎患者肠道菌群水平、肠黏膜ICAM-1、MMP-9蛋白表达的影响 被引量:3
7
作者 高飞 张杰伟 +1 位作者 徐琪 林怡 《临床和实验医学杂志》 2023年第13期1378-1382,共5页
目的 探讨复方苦参肠炎康片联合美沙拉嗪治疗对溃疡性结肠炎(UC)患者肠道菌群水平、肠黏膜细胞间黏附分子(ICAM-1)、基质金属蛋白酶-9(MMP-9)蛋白表达的影响。方法 前瞻性选取2020年1月至2022年5月海南医学院第一附属医院消化内科收治... 目的 探讨复方苦参肠炎康片联合美沙拉嗪治疗对溃疡性结肠炎(UC)患者肠道菌群水平、肠黏膜细胞间黏附分子(ICAM-1)、基质金属蛋白酶-9(MMP-9)蛋白表达的影响。方法 前瞻性选取2020年1月至2022年5月海南医学院第一附属医院消化内科收治的UC患者76例,按照随机数字表法将其分为对照组和观察组,每组38例。两组均给予常规对症治疗,对照组给予美沙拉嗪治疗,观察组在对照组的治疗基础上加予复方苦参肠炎康片治疗。观察两组临床疗效和电子肠镜黏膜疗效,比较治疗前及治疗6周后的肠道菌群水平和肠黏膜ICAM-1、MMP-9蛋白表达情况,评估两组药物安全性,对两组进行为期6个月的随访,记录两组复发率。结果 观察组的临床总有效率为94.74%,显著高于对照组(65.79%),观察组的电子肠镜黏膜总有效率为92.11%,显著高于对照组(65.79%),差异均有统计学意义(P<0.05)。治疗后,两组的肠道中双歧杆菌、乳酸杆菌的菌落数量较治疗前均显著增加,且观察组中分别为(9.92±1.82)、(7.29±1.46)lgCFU/g,显著高于对照组[(8.55±1.27)、(6.41±1.04)lgCFU/g],差异均有统计学意义(P<0.05);两组治疗前后和组间治疗后的肠球菌、肠杆菌的菌群数量比较,差异均无统计学意义(P>0.05)。治疗后,两组的肠黏膜ICAM-1、MMP-9蛋白表达水平均较治疗前下降,且观察组的肠黏膜ICAM-1、MMP-9蛋白表达水平分别为0.012±0.008、0.028±0.008,均显著低于对照组(0.019±0.009、0.036±0.012),差异均有统计学意义(P<0.05)。观察组的不良反应总发生率为2.63%,与对照组的5.26%比较,差异无统计学意义(P>0.05)。随访6个月,两组均未发现明显复发病例。结论 复方苦参肠炎康片、美沙拉嗪联合治疗UC疗效确切,可提高肠黏膜修复疗效,纠正肠道菌群水平失衡,可能是通过下调肠黏膜ICAM-1、MMP-9蛋白表达的作用机制,以改善肠黏膜通透性和修复肠黏膜屏障,不良反应少,复发率极低,临床应用安全性高。 展开更多
关键词 溃疡性结肠炎 复方苦参肠炎康片 美沙拉嗪 肠道菌群 细胞间黏附分子-1 基质金属蛋白酶-9
下载PDF
复方黄柏液涂剂外敷联合泡沫硬化治疗下肢静脉曲张性溃疡疗效及其对TNF-α、IL-6、CRP水平的影响 被引量:2
8
作者 靳立强 郭海涛 韩书明 《中华中医药学刊》 CAS 北大核心 2023年第11期250-253,共4页
目的分析复方黄柏液涂剂外敷联合泡沫硬化剂治疗下肢静脉曲张性溃疡的临床疗效及其对患者肿瘤坏死因子-α(Tumor necrosis factor-α,TNF-α)、白细胞介素-6(Interleukin-6,IL-6)、C反应蛋白(C-reactive protein,CRP)水平的影响。方法选... 目的分析复方黄柏液涂剂外敷联合泡沫硬化剂治疗下肢静脉曲张性溃疡的临床疗效及其对患者肿瘤坏死因子-α(Tumor necrosis factor-α,TNF-α)、白细胞介素-6(Interleukin-6,IL-6)、C反应蛋白(C-reactive protein,CRP)水平的影响。方法选取2020年1月—2022年1月收治的122例下肢静脉曲张性溃疡患者作为研究对象。按随机数字表法分为两组,观察组61例,采用复方黄柏液涂剂外敷联合泡沫硬化剂治疗,对照组61例,采用泡沫硬化剂注射治疗。统计分析两组临床疗效、治疗前后TNF-α、IL-6、CRP、疼痛视觉模拟评分法(VAS)评分、静脉临床严重程度评分(VCSS)及并发症数据。结果观察组临床总有效率为93.44%(57/61),明显高于对照组的78.69%(48/61),相比差异有统计学意义(χ^(2)=4.200,P=0.040);两组治疗1个月后血清TNF-α、IL-6及CRP水平均明显下降(P<0.001),观察组治疗1个月后血清TNF-α、IL-6及CRP水平显著低于对照组,相比差异有统计学意义(P<0.001);两组治疗1个月后VAS评分及VCSS评分均明显降低(P<0.01),观察组治疗1个月后VAS评分及VCSS评分显著低于对照组,相比差异有统计学意义(P<0.01);观察组并发症总发生率为6.56%,低于对照组的16.39%,相比差异无统计学意义(χ^(2)=2.311,P=0.128)。结论复方黄柏液涂剂外敷联合泡沫硬化剂治疗下肢静脉曲张性溃疡,能够有效抑制炎症因子表达,降低静脉临床严重程度评分,减轻疼痛,提高临床疗效,并发症少,能够兼顾安全性与有效性,值得临床予以推广应用。 展开更多
关键词 下肢静脉曲张性溃疡 复方黄柏液涂剂 泡沫硬化剂 临床疗效 炎症因子
下载PDF
Duration of treatment with 5-aminosalicylic acid compounds 被引量:1
9
作者 T Moshkovska JF Mayberry 《World Journal of Gastroenterology》 SCIE CAS CSCD 2007年第32期4310-4315,共6页
The development of 5-aminosalicylic acid (5-ASA) therapy as a life long treatment for ulcerative colitis is reviewed from its origins in the 1940s to the present day. The drug was designed to treat rheumatoid arthriti... The development of 5-aminosalicylic acid (5-ASA) therapy as a life long treatment for ulcerative colitis is reviewed from its origins in the 1940s to the present day. The drug was designed to treat rheumatoid arthritis,but was found helpful in the management of nine patients with ulcerative colitis. This discovery preceded the emergence of the clinical trial as a tool for assessing a new drug's efficacy; as a result it lacked scientific rigour and was selective in its presentation of results. Nevertheless it identified the future cornerstone of therapy in ulcerative colitis. In 1962,the first double blind controlled trial of sulphasalazine was conducted on 40 patients. Outcome measures were subjective and included symptoms and an assessment of the rectal mucosa. In 1973,the first two papers on the role of sulphasalazine in maintenance of remission were published. Both used placebo controls and had a stratified design. Outcomes were measured using "an intention to treat" approach. The British study of 64 patients used both subjective and objective criteria to assess outcomes. Patients on placebo had a relapse rate four times patients on active treatment and this founded the basis for a life long approach to therapy with 5-ASA compounds in ulcerative colitis. However,in 1985,a small "on demand" study of 32 patients suggested this approach might be as effective as continuous treatment. Some support for this view came from an Italian study which showed no benefit to continued treatment for those in remission for two years or more. The central problem these studies identify is that of adherence to treatment in the long-term. Few studies have considered patients' attitudes to continuous therapy and it is an area that needs further investigation. 展开更多
关键词 ulcerative colitis 5-aminosalicylic acid compounds Sulphasalazine mesalazine adherance trials
下载PDF
A mild,efficient and selective iodination of aromatic compounds using iodine and 1,4-bis(triphenylphosphonium)-2-butene peroxodisulfate 被引量:1
10
作者 Rashid Badri Maryam Gorjizadeh 《Chinese Chemical Letters》 SCIE CAS CSCD 2009年第12期1439-1443,共5页
A simple and efficient method for the iodination of aromatic compounds has been achieved in the presence of iodine and 1,4- bis(triphenylphosphonium)-2-butene peroxodisulfate.
关键词 Iodoaromafic compounds Aromatic compounds IODINE 1 4-Bis(triphenylphosphonium)-2-butene peroxodisulfate
下载PDF
高效液相色谱-高分辨质谱联合Compound Discoverer软件分析安化黑茶水溶性成分 被引量:2
11
作者 何青科 邹子爵 +3 位作者 易守福 陈同强 宋阳 向俊 《食品安全质量检测学报》 CAS 北大核心 2021年第13期5283-5291,共9页
目的建立安化黑茶中水溶性成分的快速分离和确证方法。方法采用90℃热水恒温提取安化黑茶样品中水溶性成分,采用高效液相色谱-高分辨质谱仪对其中的水溶性提取物进行分离测定,利用Compound Discoverer软件分析和匹配实验测定的准确质量... 目的建立安化黑茶中水溶性成分的快速分离和确证方法。方法采用90℃热水恒温提取安化黑茶样品中水溶性成分,采用高效液相色谱-高分辨质谱仪对其中的水溶性提取物进行分离测定,利用Compound Discoverer软件分析和匹配实验测定的准确质量数,通过对保留时间、多级质谱、特征碎片离子等特征信息检索,对不同基地、不同工艺的安化黑茶中水溶性化合物进行初步确证。结果得到了不同基地种植的安化黑毛茶的特征性化合物,分析了不同加工工艺的黑茶中主要化合物的变化趋势,并首次发现安化黑茶中含有环磷酸腺苷和其他6种未知新化合物。结论本研究为安化黑茶品质保证和质量控制提供了一种新的技术参考依据,为生产者通过安化黑茶加工工艺来控制成品茶中水溶性成分含量提供科学的理论依据,为安化黑茶药理活性物质开发提供了新的研究方向。 展开更多
关键词 高效液相色谱-高分辨质谱法 安化黑茶 compound Discoverer软件 水溶性成分
下载PDF
Efficacy of compound Bai Yu San in treating diabetic skin ulcer 被引量:1
12
作者 Yun-Xia GE Xiao-Rong LIU +3 位作者 Bei WANG Yong ZHANG Jia-Jia TONG Dou-Dou LI 《Journal of Integrative Nursing》 2020年第1期7-10,共4页
Objective:To assess the efficacy of compound Bai Yu San(CBYS)as a new treatment option,in healing diabetic skin ulcer.Materials and Methods:A total of 64 diabetic patients with skin ulcer were enrolled and randomly as... Objective:To assess the efficacy of compound Bai Yu San(CBYS)as a new treatment option,in healing diabetic skin ulcer.Materials and Methods:A total of 64 diabetic patients with skin ulcer were enrolled and randomly assigned to experimental group(n=33)and control group(n=31).In the control group,normal saline(NS)was used to cleanse the wound.After debridement,the wound was dressed with modern materials.In the experimental group,the NS‑cleansed wound was dressed with CBYS.The infection rate,healing rate,treatment cost,and patient satisfaction between the two groups were compared.Results:On the 35th day after treatment,the infection rate and healing rate showed no between‑group difference(P>0.05);the experimental group showed lower treatment cost and higher satisfaction than the control group(P<0.05).Conclusion:As a new treatment option for diabetes‑induced skin ulcer,CBYS can effectively control the infection,promote the healing,reduce treatment cost,and increase patient satisfaction.Dressing with CBYS can be clinically replicated in the treatment of diabetic skin ulcer. 展开更多
关键词 compound Bai Yu powder diabetic skin ulcer patient satisfaction treatment cost
下载PDF
EP4 agonist alleviates indomethacin-induced gastric lesions and promotes chronic gastric ulcer healing 被引量:1
13
作者 Wha Bin Im Yariv Donde Larry A Wheeler 《World Journal of Gastroenterology》 SCIE CAS CSCD 2009年第41期5149-5156,共8页
AIM: To investigate EP4-selective agonist effect on indomethacin-induced gastric lesions and on the spontaneous healing of chronic gastric ulcers. METHODS: In a mouse model of gastric bleeding with high dose of indo... AIM: To investigate EP4-selective agonist effect on indomethacin-induced gastric lesions and on the spontaneous healing of chronic gastric ulcers. METHODS: In a mouse model of gastric bleeding with high dose of indomethacin (20 mg/kg), an EP4-selective agonist was administered orally. Stomach lesions and gastric mucous regeneration were monitored. In a mouse model of chronic gastric ulcer induced by acetic acid, EP4 agonist effect on the healing of chronic gastric ulcer was evaluated in the presence or absence of low dose indomethadn (3 mg/kg). In cultured human gastric mucous cells, EP4 agonist effect on indomethacin- induced apoptosis was assessed by flow cytometry. RESULTS: The EP4-selective agonist reduced high dose indomethacin-induced acute hemorrhagic damage and promoted mucous epithelial regeneration. Low-dose indomethacin aggravated ulcer bleeding and inflammation, and delayed the healing of the established chronic gastric ulcer. The EP4 agonist, when applied locally, not only offset indomethacin-induced gastric bleeding and inflammation, but also accelerated ulcer healing. In the absence of indomethacin, the EP4 agonist even accelerated chronic gastric ulcer healing and suppressed inflammatory cell infiltration in the granulation tissue. In vitro, the EP4 agonist protected human gastric mucous cells from indomethacin-induced apoptosis.CONCLUSION: EP4-selective agonist may prevent indomethacin-induced gastric lesions and promote healing of existing and i ulcers, via promoting mucous epithelial cells. proliferation and survival of mucous epithelial cells. 展开更多
关键词 Prostaglandin E2 Non-steroidal anti-inflam- matory drugs Gastric bleeding Gastric ulcer EP4- subtype receptor
下载PDF
Hydrothermal Synthesis,Crystal Structure and Fluorescence Spectrum Studies of a Novel Supramolecular Compound {[2-(2-Pyridyl)benzimidazoleH_2]_2·[BiCl_6]·Cl} 被引量:1
14
作者 邱东方 李玉玲 +1 位作者 王宏伟 郭应臣 《Chinese Journal of Structural Chemistry》 SCIE CAS CSCD 2010年第5期811-815,共5页
A novel supramolecular compound,{[2-(2-pyridyl)benzimidazoleH2]2·[BiCl6]·Cl},was synthesized by the hydrothermal reaction of o-phenylenediamine and α-pyridinecarboxylic acid with BiCl3 in 6.0 mol·L-1... A novel supramolecular compound,{[2-(2-pyridyl)benzimidazoleH2]2·[BiCl6]·Cl},was synthesized by the hydrothermal reaction of o-phenylenediamine and α-pyridinecarboxylic acid with BiCl3 in 6.0 mol·L-1 HCl solution,and characterized by elemental analysis,IR,X-ray single-crystal diffraction and photoluminescence spectroscopy.The crystal (C24H22N6Cl7Bi,Mr= 851.61) belongs to the triclinic system,space group P1 with a =7.2887(18),b =9.548(2),c= 12.469(3),α=85.306(4),β=82.814(4),γ=71.349(4)°,Z=1,V=814.9(3)3,Dc=1.735 g/cm3,μ(MoKα)=6.007 mm-1,F(000)=410,R=0.0307 and wR=0.0787.The bismuth ion and six chlorine ions construct a distorted octahedral configuration.The three-dimensional supramolecular network is built from electrostatic attractions,hydrogen bonds and π-π interaction between the BiCl6 anion,Cl anion and [2-(2-pyridyl)benzimidazoleH2] cation.The photoluminescence spectroscopy study shows that the title compound has a blue fluorescent emission at 450 nm in the solid state. 展开更多
关键词 2-(2-pyridyl)benzimidazole supramolecular compound hydrothermal synthesis crystal structure photoluminescence spectroscopy
下载PDF
Magnetic and Transport Properties of La_(0.5-x)Nd_xBa_(0.5) CoO_3 Compounds 被引量:1
15
作者 张汝贞 刘宜华 +3 位作者 王成建 黄宝歆 季刚 梅良模 《Journal of Rare Earths》 SCIE EI CAS CSCD 2003年第5期558-562,共5页
Substituting effects of Nd for La in La 0.5 Ba 0.5 CoO 3 compounds were studied systematically. The results show that Nd doping does not change the itinerant properties of the Co3d electrons. The molecular ma... Substituting effects of Nd for La in La 0.5 Ba 0.5 CoO 3 compounds were studied systematically. The results show that Nd doping does not change the itinerant properties of the Co3d electrons. The molecular magnetic moment of the materials decreases monotonically with increasing Nd dopant. When Nd content x ≥0.45, a magnetic phase separation appears in the materials. When x ≤0.45, the Curie temperature decreases monotonically with increasing Nd dopant. This is due to the size effects of the rare earth ions. The electric resistance measurements show that in the studied temperature range, the conduction of the materials belongs to the thermo diffusion conduction below the Curie temperature, while it belongs to the variable range hopping conduction of polarons over the Curie temperature. 展开更多
关键词 metal materials La 0.5- x Nd x Ba 0.5 CoO 3 compounds size effect itinerant electrons charge transfer rare earths
下载PDF
西地碘片联合FE复合酶漱口液对ROU患者EGF、E-selectin水平的影响
16
作者 黎炜 郭盼 董彬 《标记免疫分析与临床》 CAS 2023年第2期237-240,288,共5页
目的通过观察复发性口腔溃疡(ROU)患者表皮生长因子(EGF)、E-选择素(E-selectin)水平变化,评价西地碘片联合FE复合酶漱口液治疗的应用价值。方法选取我院于2019年3月至2020年12月收治的160例ROU患者,随机分为对照组和研究组,各为80例。... 目的通过观察复发性口腔溃疡(ROU)患者表皮生长因子(EGF)、E-选择素(E-selectin)水平变化,评价西地碘片联合FE复合酶漱口液治疗的应用价值。方法选取我院于2019年3月至2020年12月收治的160例ROU患者,随机分为对照组和研究组,各为80例。对照组接受FE复合酶漱口液,研究组在此基础上联合西地碘片。对比两组疗效、唾液EGF、E-selectin水平变化、免疫功能,随访5个月,观察两组患者复发情况。结果研究组的临床总有效率高于对照组(P<0.05)。研究组治疗后EGF、E-selectin水平更低(P<0.05)。与对照组相比,研究组治疗后CD8^(+)更低,CD3^(+)、CD4^(+)、CD4^(+)/CD8^(+)更高(P<0.05)。研究组随访期间的复发率低于对照组(P<0.05)。结论西地碘片联合FE复合酶漱口液治疗ROU患者,可提高机体免疫功能,降低EGF、E-selectin水平,具有较好的临床应用价值。 展开更多
关键词 西地碘片 FE复合酶漱口液 复发性口腔溃疡 表皮生长因子 E-选择素
下载PDF
基于p38 MARK/MMP-9信号通路探讨自拟复方愈溃汤对UC大鼠肠道炎症、氧化应激及屏障功能的影响
17
作者 袁翠 雷晓红 莫黎 《医学综述》 CAS 2023年第14期2891-2896,2902,共7页
目的探讨自拟复方愈溃汤通过p38促分裂原活化的蛋白激酶(MAPK)/基质金属蛋白酶9(MMP-9)通路对溃疡性结肠炎(UC)大鼠肠道炎症、氧化应激及屏障功能的影响。方法选取雄性Wistar大鼠75只,采用随机数字表法分为对照组、模型组、低、中、高... 目的探讨自拟复方愈溃汤通过p38促分裂原活化的蛋白激酶(MAPK)/基质金属蛋白酶9(MMP-9)通路对溃疡性结肠炎(UC)大鼠肠道炎症、氧化应激及屏障功能的影响。方法选取雄性Wistar大鼠75只,采用随机数字表法分为对照组、模型组、低、中、高剂量汤药组,每组15只。除对照组外,其余各组均以2,4,6-三硝基苯磺酸/乙醇致炎法建立UC大鼠模型。其中,对照组和模型组以0.9%氯化钠溶液灌胃,低、中、高剂量汤药组分别以自拟复方愈溃汤4.2 g/(kg·d)、8.4 g/(kg·d)、16.8 g/(kg·d)灌胃。比较各组大鼠的一般情况,结肠组织疾病活动指数(DAI)评分和组织病理评分、炎症因子[肿瘤坏死因子-α(TNF-α)、白细胞介素-6(IL-6)和γ干扰素(INF-γ)]、氧化应激指标[超氧化物歧化酶(SOD)、丙二醛(MDA)、谷胱甘肽(GSH)]、肠黏膜屏障功能蛋白[闭锁蛋白(Occludin)、闭锁小带蛋白-1(ZO-1)]及p-p38 MAPK/p38 MAPK、MMP-9蛋白表达的变化。结果低、中、高剂量汤药组DAI评分和组织病理评分均低于模型组[(2.55±0.50)分、(1.50±0.32)分、(0.82±0.25)分比(3.25±0.65)分,(5.15±1.14)分、(3.00±0.78)分、(2.00±0.65)分比(6.33±1.30)分],且低、中、高剂量汤药组DAI评分和组织病理评分呈剂量依赖性降低趋势(P<0.05)。低、中、高剂量汤药组TNF-α、IL-6、IFN-γ水平均低于模型组,且低、中、高剂量汤药组TNF-α、IL-6、IFN-γ水平呈剂量依赖性降低趋势(P<0.05)。低、中、高剂量汤药组SOD、GSH水平均高于模型组,MDA水平均低于模型组;且低、中、高剂量汤药组SOD、GSH水平呈剂量依赖性升高趋势,MDA水平呈剂量依赖性降低趋势(P<0.05)。低、中、高剂量汤药组Occludin、ZO-1表达均高于模型组,p-p38 MAPK/p38 MAPK与MMP-9表达均低于模型组;且低、中、高剂量汤药组Occludin、ZO-1表达呈剂量依赖性升高趋势,p-p38 MAPK/p38 MAPK与MMP-9表达呈剂量依赖性降低趋势(P<0.05)。结论自拟复方愈溃汤能通过抑制p38 MARK信号通路的活化和MMP-9蛋白的表达,降低UC大鼠结肠组织炎症因子水平,减轻氧化应激反应,改善肠黏膜上皮屏障功能。 展开更多
关键词 溃疡性结肠炎 自拟复方愈溃汤 p38促分裂原活化的蛋白激酶 基质金属蛋白酶9 氧化应激
下载PDF
2D-QSAR Studies on Pyrazole Compounds Containing Pyrimidine Amino
18
作者 魏庆莉 高君 +1 位作者 和富金 张书圣 《Chinese Journal of Structural Chemistry》 SCIE CAS CSCD 北大核心 2007年第10期1232-1238,共7页
The quantitative structure-activity relationship (QSAR) of 16 pyrazole compounds was studied by ab initio method at the HF/3-21G level using Guassian03 soft. The optimized structures together with some characteristi... The quantitative structure-activity relationship (QSAR) of 16 pyrazole compounds was studied by ab initio method at the HF/3-21G level using Guassian03 soft. The optimized structures together with some characteristic and electric parameters of the title compounds were obtained; some stereo-parameters were calculated by HyperChem software. Stepwise multiple regression method was adopted to establish bi- and tri-parametric models between biological activity and some parameters. The lager △E and logP, the higher biological activity; and the biological activity would be promoted with the smaller μ, QN and QPYRA. It provided a theory direction to synthesize some compounds with high activity. 展开更多
关键词 pyrimidine amino pyrazole compounds 2D-QSAR ab initio HF/3-21G
下载PDF
Solid-phase Synthesis of Unsaturated β-Dicarbonyl Compounds from Polymer-supported 4-(Phenylseleno)morpholine
19
作者 Xiao Ling LIU Xing Cong WANG +1 位作者 Shou Ri SHENG Xian HUANG 《Chinese Chemical Letters》 SCIE CAS CSCD 2004年第9期1009-1010,共2页
The solid-phase synthesis of unsaturated ?dicarbonyl compounds has been reported.
关键词 Solid phase organic synthesis 4-(phenylseleno)morpholine α-formylcycloanone unsaturated β-dicarbonyl compound.
下载PDF
Meta-analysis on Efficacy and Safety of Compound Stomachache Inflammation Caused by Helicobacter Pylori
20
作者 LAI Su-yu XI Jun-yu +2 位作者 LYU Jian SHI Bu-wen XIE Yan-ming 《World Journal of Integrated Traditional and Western Medicine》 2022年第6期1-10,共10页
Objective:To systematically evaluate the efficacy and safety of Compound Stomachache Capsule(复方胃痛胶囊)in the treatment of digestive ulcer and inflammation Helicobacter pylori-Peptic Ulcer(Hp-PU)caused by Helicobac... Objective:To systematically evaluate the efficacy and safety of Compound Stomachache Capsule(复方胃痛胶囊)in the treatment of digestive ulcer and inflammation Helicobacter pylori-Peptic Ulcer(Hp-PU)caused by Helicobacter pylori(Hp).Methods:Randomized controlled trials(RCTs)of Compound Stomachache Capsule(复方胃痛胶囊)in the treatment of Hp-PU were screened out by searching CNKI,VIP,Wanfang,China Biomedical Literature Service System,Cochrane Library,Pub Med,EMbase,Web of Science and Clinical Trials.gov.Meta-analysis was performed with Rev Man 5.4 software.Results:Three RCTs were included,including 331 patients of 166 patients in the experimental group(Compound Stomachache Capsule(复方胃痛胶囊)+conventional western medicine treatment)and 165 patients in the control group(conventional western medicine treatment).Meta-analysis data showed that Hp eradication rate(RR=1.10,95%CI[1.01-1.19],P=0.03)was significantly higher in the experimental group than in the control group.The experimental group was superior to the control group in improving clinical symptoms(RR=1.59,95%CI[1.22-2.06],P=0.0006).Conclusion:According to the current evidence,the Compound Stomachache Capsule(复方胃痛胶囊)combined with conventional Western medicine treatment can improve the Hp eradication rate of Hp-PU,relieve symptoms,and do not increase the incidence of adverse reactions.However,the number of included studies is small and the sample size is small,so its effectiveness and safety need further verification. 展开更多
关键词 Dystematic evaluation compound Stomachache Capsule(复方胃痛胶囊) Helicobacter Pylori(Hp) Peptic ulcer(PU) Digestive system inflammation Randomized controlled trial(RCTs) Effectivity Safety META-ANALYSIS
下载PDF
上一页 1 2 28 下一页 到第
使用帮助 返回顶部